Download Files:
TL13-22
SKU
HY-136194-5mg
Category Reference compound
Tags Anaplastic lymphoma kinase (ALK), Cancer, Protein Tyrosine Kinase/RTK
$998
Only 1000 item(s) left in stock.
Products Details
Product Description
– TL13-22 is a negative control for TL13-12 (HY-122582) and a potent ALK inhibitor with an IC50 of 0.54 nM. TL13-22 does not degrade ALK in cells[1].
Web ID
– HY-136194
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C45H55ClN10O9S
References
– [1]Chelsea E Powell, et al. Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK). J Med Chem. 2018 May 10;61(9):4249-4255.
CAS Number
– 2229036-65-9
Molecular Weight
– 947.50
SMILES
– O=C(NCCOCCOCCN1CCN(C2=CC=C(NC3=NC=C(Cl)C(NC4=CC=CC=C4S(=O)(C(C)C)=O)=N3)C(OC)=C2)CC1)CNC5=CC=CC(C(N6C7C(NCCC7)=O)=O)=C5C6=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Anaplastic lymphoma kinase (ALK)
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.